IP Library Granted Patent US 7,684,857
Granted Patent B2
US 7,684,857 · App. 10/492,487 · Granted Mar 23, 2010

Device for medicine delivery by intraocular iontophoresis or electroporation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,684,857
App. No.
10/492,487
Granted
Mar 23, 2010
Kind
B2
Abstract

The invention concerns a device for ocular delivery of an active principle by peroperative intraocular iontophoresis or electroporation comprising a reservoir ( 7 ) for receiving a solution comprising the active principle, means for diffusing ( 8, 6 ) the active principle connected to the reservoir, means for injecting ( 4 ) the solution into the reservoir, and means ( 5 ) for exerting suction of the content of the reservoir during an injection of the solution therein by the injection means.

Claims (34)

1. A device for an ocular application of an active principle by peroperative intraocular iontophoresis or electroporation within an ocular globe of an eye, comprising:

a reservoir arranged for being at least partly introduced into the ocular globe, close to cells to be treated, the reservoir receiving a solution comprising the active principle;

means for injecting the solution into the reservoir;

means for sucking up contents of the reservoir during injection of the solution into the reservoir by the injection; and

a porous reservoir wall of the reservoir, the porous reservoir wall being folly introduced into the ocular globe, at least a portion of which is configured to provide porous access to the reservoir, the porous access configured to allow molecules of the active principle to pass through the porous reservoir wall only under the effect of an electric field.

2. The device as claimed in claim 1 , wherein the means for injecting comprising an injection tube and the means for sucking comprising a suction tube, the injection tube and the suction tube extend inside one another and can be connected to the reservoir.

3. The device as claimed in claim 1 , wherein the reservoir is arranged at a distal end of a probe.

4. The device as claimed in claim 3 , wherein the distal end of the probe forms an angle (α) with respect to the direction along with the probe mainly extends.

5. The device as claimed in claim 4 , wherein the angle is between 90° and 170°.

6. The device as claimed in claim 5 , wherein the angle is around 135°.

7. The device as claimed in claim 3 , wherein the porous reservoir wall includes a porous end-piece positioned at a distal end of the probe surrounding the reservoir.

8. The device as claimed in claim 1 , comprising an injection tube and a suction tube which extend into a probe.

9. The device as claimed in claim 1 , wherein an iontophoresis or electroporation electrode extends in a probe, the reservoir being arranged at a distal end of the probe.

10. The device as claimed in claim 1 , wherein the porous reservoir wall comprises a plurality of micro-orifices passing through the wall.

11. The device as claimed in claim 1 , wherein at least a portion of the porous reservoir wall comprises a balloon having a semi-permeable membrane.

12. The device as claimed in claim 1 , wherein the porous reservoir wall defines an orifice, the device including a porous membrane positioned to plug the orifice and provide porous access to the reservoir.

13. The device as claimed in claim 1 , further comprising an optical fiber that can be connected to a light source and arranged so as to illuminate the environment of the diffusion means, in particular of the target cells that are to be treated.

14. The device as claimed in claim 13 , comprising second optical fiber that can be connected to a camera and arranged so as to record images of the environment of the diffusion means, in particular of the target cells that are to be treated.

15. The device as claimed in claim 1 , wherein the porous reservoir wall defines an orifice, the device including an absorbent material positioned to plug the orifice and provide porous access to the reservoir.

16. The device as claimed in claim 1 , wherein the at least a portion of the porous reservoir wall providing porous access comprises a one or more micro-orifices having a mean diameter of between about 1 μm and about 10 μm.

17. A probe for an ocular application of an active principle by intraocular iontophoresis or electroporation within an ocular globe of an eye, comprising:

a reservoir arranged for being at least partly introduced into the ocular globe, close to cells to be treated, the reservoir receiving a solution comprising the active principle; an injection tube for injecting the solution into the reservoir;

a suction tube for sucking up the contents of the reservoir; and

a porous reservoir wall of the reservoir, the porous reservoir wall being fully introduced into the ocular globe, at least a portion of which is configured to provide porous access to the reservoir, the porous access configured to allow molecules of the active principle to pass through the porous reservoir wall only under the effect of an electric field.

18. The device as claimed in claim 17 , wherein the at least a portion of the porous reservoir wall providing porous access comprises a one or more micro-orifices having a mean diameter of between about 1 μm and about 10 μm.

19. The device as claimed in claim 17 , wherein the porous reservoir wall comprises a plurality of micro-orifices passing though the wall.

20. The device as claimed in claim 19 , wherein the micro-orifices have a mean diameter of between about 0.01 mm and 0.1 mm.

21. A device for an ocular application of an active principle by peroperative intraocular iontophoresis or electroporation, comprising:

a probe having proximal end and a distal end, comprising:

a reservoir at the distal end for receiving a solution comprising the active principle;

at least two fluid channels in fluid communication with the reservoir; and

an electrode disposed with the probe configured to create an electric field for applying the active principles to an ocular component of an eye;

at least one of the fluid channels configured to deliver the active principles to the reservoir; and

at least another fluid channel configured to remove contents from the reservoir during the delivery of the active principles.

Assignments (3)
CHANGE OF LEGAL ENTITY Recorded Jan 3, 2008
From: EYEGATE PHARMA S.A.
To: EYEGATE PHARMA S.A.S.
Reel/Frame 020312/0374 →
CHANGE OF NAME Recorded Oct 31, 2006
From: OPTIS FRANCE S.A.
To: EYEGATE PHARMA S.A.
Reel/Frame 018454/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2005
From: BEHAR, FRANCINE; ROY, PIERRE
To: OPTIS FRANCE S.A.
Reel/Frame 017135/0660 →